SYDNEY–(BUSINESS WIRE)– #100thStore–Oscar Wylee has announced the opening of its 100th retail store in Albany – New Zealand, with trading to commence from 9th August 2021. This comes on the back of the eyewear retailer opening 27 new stores across A…
Author: Business Wire
Advanced Clinical’s Graham Belgrave Named to the 2021 PharmaVOICE 100 List of Distinguished Leaders
DEERFIELD, Ill.–(BUSINESS WIRE)–Graham Belgrave, SVP of European Operations at Advanced Clinical, has been recognized as a distinguished leader on the 2021 PharmaVOICE 100 list.
Fabrinet to Announce Fourth Quarter and Fiscal-Year 2021 Financial Results on August 16, 2021
BANGKOK–(BUSINESS WIRE)– #EarningsDate–Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, tod…
Aldeyra Therapeutics Schedules Webcast and Conference Call to Report Second-Quarter 2021 Financial Results and Discuss Recent Business Highlights
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call at 8:00 a.m. ET Thursday, August 5, 2021 to report financial results for the quarter ended June 30, 2021 and discuss recent business high…
Ocular Therapeutix™ Announces First Patient Dosed in U.S.-based Phase 1 Clinical Trial of OTX-TKI for the Treatment of Wet Age-Related Macular Degeneration
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
LENSAR to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s sec…
National Vision Holdings, Inc. Announces Second Quarter 2021 Earnings Release and Conference Call
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its second quarter 2021 financial results before the market opens on Thursday, August 12, 2021. The Company will host a conferen…
Global Graves' Ophthalmopathy Disease Clinical Trials Review: H1, 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Graves’ Ophthalmopathy Disease – Global Clinical Trials Review, H1, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. This report provides an overview of Graves’ Ophthalmopathy Clinical trials scen…
FDA Accepts Application for Genentech’s Faricimab for the Treatment of Wet Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME)
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA), under Pr…
Iveric Bio to Report Second Quarter 2021 Financial Results and Host Conference Call on Wednesday, August 4, 2021
NEW YORK–(BUSINESS WIRE)–Iveric Bio announced that it will report its second quarter 2021 financial and operating results on Wednesday, August 4, 2021.
Ocular Therapeutix™ To Report Second Quarter 2021 Financial Results
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…
Aerie Pharmaceuticals to Announce Second Quarter 2021 Financial Results and Host Conference Call on Wednesday, August 4, 2021
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
Worldwide Optical Imaging System Industry to 2026 – Burgeoning Demand for Optical Imaging Techniques in Drug Discovery Processes Presents Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optical Imaging System Market Research Report by Product, by End User, by Therapeutic Area, by Application, by Region – Global Forecast to 2026 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.c…
Tesseract Health Names Diagnostics Innovator Dr. Vicky Demas CEO
GUILFORD, Conn.–(BUSINESS WIRE)–Tesseract Health Inc. has named industry veteran and entrepreneur Vasiliki (Vicky) Demas, Ph.D. as its Chief Executive Officer.
IACTA Pharmaceuticals Appoints Yogesh Bahl as Chief Financial Officer and Eric Carter, M.D., Ph.D., as Chief Medical Officer
IRVINE, Calif.–(BUSINESS WIRE)–IACTA Pharmaceuticals Appoints Yogesh Bahl as Chief Financial Officer and Eric Carter, M.D., Ph.D., as Chief Medical Officer
Harrow Health Acquires Patented Ophthalmic Surgical Drug Candidate from Sintetica
NASHVILLE, Tenn. & MENDRISIO, Switzerland–(BUSINESS WIRE)—- $HROW–Harrow Health Acquires Patented Ophthalmic Surgical Drug Candidate from Sintetica
Ocular Hypertension Market Insight, Epidemiology and Market Forecast Report 2021-2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ocular Hypertension Market Insight, Epidemiology and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering. This ‘Ocular Hypertension – Market Insights, Epidemiology, and Market Forecast – 2030…
参天制药和国际防盲协会合作，以实际行动执行联合国大会首个确认眼部健康与可持续发展之间存在联系的决议
日本大阪–(BUSINESS WIRE)–(美国商业资讯)–参天制药株式会社（Santen Pharmaceutical Co., Ltd.，简称“参天”）今天宣布，公司将与国际防盲协会(International Agency for the Prevention of Blindness, IAPB)采取联合行动，以执行联合国大会关于眼部健康的决议A/75/L.108。在与IAPB合作数月之后，参天的此次行动旨在倡导采取全球行动，以改善基本眼部保健服务的可及性。 参天致力于降低眼部疾病患者…
Samenvatting: Santen en IAPB ondernemen actie om de allereerste resolutie van de Algemene Vergadering van de VN te implementeren waarin het verband wordt erkend tussen ooggezondheid en duurzame ontwikkeling
OSAKA, Japan–(BUSINESS WIRE)–Santen Pharmaceutical Co., Ltd. (“Santen”) heeft vandaag aangekondigd dat Santen, in samenwerking met het International Agency for the Prevention of Blindness (IAPB), actie zal ondernemen om de Algemene Vergadering van de…
Resumen: Santen e IAPB toman medidas para implementar la primera resolución de la Asamblea General de Naciones Unidas que reconoce la relación entre la salud ocular y el desarrollo sostenible
OSAKA, Japón–(BUSINESS WIRE)–Santen Pharmaceutical Co., Ltd. (“Santen”) ha anunciado hoy que la empresa, en colaboración con la International Agency for the Prevention of Blindness (IAPB), adoptará medidas para implementar la resolución A/75/L.108 de…